{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:17:51Z","timestamp":1760426271340,"version":"3.32.0"},"reference-count":64,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY1093"],"award-info":[{"award-number":["2025KY1093"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Evidence Based Medicine"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Off\u2010label drug use (OLDU) is a common practice in health care institutions, and numerous guidance documents have been developed to guide the management of OLDU in China. This scoping review aims to compare these documents and identify existing issues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PubMed, EMbase, three Chinese databases, the National Public Service Platform for Standards Information and the official websites of pharmaceutical\u2010related associations were searched to identify guidance documents relevant to the management of OLDU for Chinese health care institutions. We extracted and compared the recommended practices for various aspects of OLDU management, including management systems, organizational structure, prerequisites for OLDU, approval processes, evidence\u2010based evaluation, informed consent, and other related aspects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 16 guidance documents were included, comprising 12 expert consensuses, 2 practice guidelines, and 2 group standards. Only six documents provide specific requirements for the establishment of management systems. Management of OLDU requires involvement from multiple departments or committees, yet only a few documents explicitly delineate the supervisory authority, and the responsibilities of the parties involved. These documents also show significant disparities in their approval process, evidence\u2010based evaluation, and informed consent recommendations. Furthermore, only a minority of the documents provide specific requirements for training and assessments focused on OLDU and improving adverse reaction monitoring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These guidance documents differ significantly in their specific recommendations for the management of OLDU and lack sufficient emphasis on certain critical aspects. It may be beneficial for health administrative authorities to promote the development of unified national guidelines.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jebm.12669","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T05:00:15Z","timestamp":1735016415000},"page":"808-821","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Guidance Documents for Off\u2010Label Drug Use Management for Chinese Health Care Institutions: A Scoping Review"],"prefix":"10.1111","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-3958","authenticated-orcid":false,"given":"Changcheng","family":"Shi","sequence":"first","affiliation":[{"name":"Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"},{"name":"China\u2010Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences &amp; Peking Union Medical College  Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical Insurance Office Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changling","family":"Wu","sequence":"additional","affiliation":[{"name":"Medical Department Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehua","family":"Dong","sequence":"additional","affiliation":[{"name":"Medical Department Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Quality Management Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyu","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Traditional Chinese Medicine Hospital of Changshan  Quzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nengming","family":"Lin","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2006.tb00689.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.04.017"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2017.05.013"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04803-1"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.1021"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.616453"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-078126"},{"issue":"1","key":"e_1_2_7_9_1","first-page":"375","article-title":"Off\u2010label Use of Antipsychotic Medications in Psychiatric Inpatients in China: A National Real\u2010World Survey","volume":"21","author":"Wang J.","year":"2021","journal-title":"BMC Psychiatry [Electronic Resource]"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09293-y"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12960-023-00832-6"},{"volume-title":"Law of the People's Republic of China on Physicians","author":"The National People's Congress of the People's Republic of China","key":"e_1_2_7_12_1"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0611-x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"issue":"4","key":"e_1_2_7_16_1","first-page":"1","article-title":"Expert Consensus on the Use of Medications for Unlabeled Uses","volume":"20","author":"Guangdong Pharmaceutical Association","year":"2010","journal-title":"Pharmacy Today"},{"volume-title":"Expert Consensus on Off\u2010Label Drug Use by the Sichuan Pharmaceutical Association","author":"Sichuan Pharmaceutical Association","key":"e_1_2_7_17_1"},{"issue":"12","key":"e_1_2_7_18_1","first-page":"841","article-title":"Expert Consensus on the Management of Off\u2010Label Drug Use in Healthcare Institutions","volume":"24","author":"Guangdong Pharmaceutical Association","year":"2014","journal-title":"Pharmacy Today"},{"issue":"2","key":"e_1_2_7_19_1","first-page":"101","article-title":"Expert Consensus on Off\u2010Label Use of Drugs","volume":"17","author":"Drug Risk Management Group, Therapeutic Drug Monitoring and Research Committee, Chinese Pharmacological Society","year":"2015","journal-title":"ADRJ"},{"issue":"2","key":"e_1_2_7_20_1","first-page":"101","article-title":"Chinese Pediatric Off\u2010Label Drug Use Expert Consensus","volume":"54","author":"Chinese Pediatric Society, Chinese Medical Association, Editorial Board of Chinese Journal of Pediatrics","year":"2016","journal-title":"Chinese Journal of Pediatrics"},{"issue":"10","key":"e_1_2_7_21_1","first-page":"681","article-title":"Expert Consensus on Pharmacoeconomic Evaluation of Off\u2010Label Drug Use","volume":"26","author":"Guangdong Pharmaceutical Association","year":"2016","journal-title":"Pharmacy Today"},{"issue":"6","key":"e_1_2_7_22_1","first-page":"361","article-title":"Expert Consensus on the Protection of Patients' Right to Informed Consent in Off\u2010Label Drug Use","volume":"29","author":"Guangdong Pharmaceutical Association","year":"2019","journal-title":"Pharmacy Today"},{"key":"e_1_2_7_23_1","unstructured":"Guangdong Pharmaceutical Association Announcement Regarding the Release of the Group Standard \u201cThe Specification of Evidence\u2010Based Pharmaceutical Evaluation Method for Off\u2010Label Drug Use \u201daccessed 23 June 2024 http:\/\/www.sinopharmacy.com.cn\/notification\/2236.html."},{"issue":"9","key":"e_1_2_7_24_1","first-page":"1261","article-title":"Expert Consensus on the Management of Extended Clinical Application of Drugs in Healthcare Institutions in Hubei Province","volume":"41","author":"Pharmaceutical Professional Committee of Hubei Province Hospital Association","year":"2022","journal-title":"Herald of Medicine"},{"issue":"1","key":"e_1_2_7_25_1","first-page":"442","article-title":"Guideline for the Management of Pediatric Off\u2010Label Use of Drugs in China (2021)","volume":"22","author":"Meng M.","year":"2022","journal-title":"BMC Pediatrics [Electronic Resource]"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2022.2120468"},{"volume-title":"Notification From the Chinese Hospital Association Regarding the Release of the Third Batch of Nine Group Standards on \u201cPharmacy Administration and Pharmacy Practice in Healthcare Institutions","author":"Chinese Hospital Association","key":"e_1_2_7_27_1"},{"first-page":"1265","volume-title":"Evidence\u2010Based Pharmacy Professional Committee of Yunnan Pharmaceutical Association, the First People's Hospital of Kunming","year":"2023","key":"e_1_2_7_28_1"},{"volume-title":"Announcement Regarding the Release of the \"Expert Consensus on off\u2010label Drug Use in Shandong Province (2023 edition)","author":"Shandong Pharmaceutical Association","key":"e_1_2_7_29_1"},{"key":"e_1_2_7_30_1","unstructured":"Health Industry Association of Heilongjiang Province Notification Regarding the Release of the \u201cExpert Consensus on Off\u2010Label Drug Use Management in Heilongjiang Province \u201daccessed 23 June 2024 http:\/\/www.hljjkcy.com\/article\/180."},{"issue":"3","key":"e_1_2_7_31_1","first-page":"476","article-title":"Expert Consensus on Off\u2010Label Drug Use Management in Guangxi Medical Institutions","volume":"41","author":"Evidence\u2010Based Pharmacy Professional Committee of Guangxi Pharmaceutical Association","year":"2024","journal-title":"Journal of Guangxi Medical University"},{"key":"e_1_2_7_32_1","unstructured":"National Health Commission of the People's Republic of China Notice on issuing the Administrative Measures for the Clinical Application of Antineoplastic Drugs (Trial) by the National Health Commission accessed 23 June 2024 http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/202012\/a7600740bed44d1db7015ca5a1be2cc0.shtml."},{"issue":"8","key":"e_1_2_7_33_1","first-page":"756","article-title":"Investigation and Countermeasure Research of Off\u2010Label Use of Drugs in Chinese Hospital","volume":"32","author":"Han Y.","year":"2016","journal-title":"Chinese Journal of Clinical Pharmacology"},{"issue":"6","key":"e_1_2_7_34_1","first-page":"684","article-title":"Evaluations of a Management System for Off\u2010Label Drug Use at Tertiary Hospitals in Guizhou Province","volume":"44","author":"Zhang R.","year":"2024","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-019-1664-7"},{"issue":"5","key":"e_1_2_7_36_1","first-page":"321","article-title":"Case Analysis of Medical Damage Liability Disputes Related to Off\u2010Label Drug Use","volume":"30","author":"Qi J.","year":"2021","journal-title":"Chinese Journal of Pharmacoepidemiology"},{"key":"e_1_2_7_37_1","unstructured":"China Judgements Online Appellate Civil Judgment on Medical Liability Disputes Involving Luo Rendi Hu Jingui and Others accessed 23 June 2024 https:\/\/wenshu.court.gov.cn\/website\/wenshu\/181107ANFZ0BXSK4\/index.html?docId=9lmXbM9x89cwzAtbZGEfqtsriz3HlcM9IYftfKhOK4L5FdILtWZTEZ\/dgBYosE2g5Idjywpur4wxcSn0oSzwkCtisX14wHh35jep4E3eZdX6kI1gvnYTkCZPHbBzAAD6."},{"key":"e_1_2_7_38_1","unstructured":"China Judgements Online Civil Appeal Judgment on Medical Liability Disputes Involving Hu Jiangang Peng Lihua and Others accessed 23 June 2024 https:\/\/wenshu.court.gov.cn\/website\/wenshu\/181107ANFZ0BXSK4\/index.html?docId=QsLWgpsZt6QWpkw1NlpwdHXUOkl1AaEpRqkZnhSn\/E+Nj2A4AJzdGJ\/dgBYosE2g5Idjywpur4wxcSn0oSzwkCtisX14wHh35jep4E3eZdVB8AgPgnbCUa1B0WgITxVq."},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.6058"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001022"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101704"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.3233\/JRS-150642"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12222"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1999.tb00191.x"},{"key":"e_1_2_7_45_1","first-page":"238","article-title":"Adverse Drug Reactions and Off\u2010Label and Unlicensed Medicines in Children: A Nested Case\u2010Control Study of Inpatients in a Pediatric Hospital","volume":"11","author":"Bellis J. R.","year":"2013","journal-title":"BMC Medicine [Electronic Resource]"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05371-7"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188354"},{"issue":"4","key":"e_1_2_7_48_1","first-page":"365","article-title":"Problems and Countermeasures of Medical Ethics Committee in China","volume":"33","author":"Zhou J.","year":"2017","journal-title":"Chinese Journal of Clinical Pharmacology"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.892574"},{"key":"e_1_2_7_50_1","unstructured":"China Judgements Online Second\u2010Instance Civil Judgment on the Medical Service Contract Dispute Between Chen Yunluo and Nanjing Maternity and Child Health Care Hospital accessed 23 June 2024 https:\/\/wenshu.court.gov.cn\/website\/wenshu\/181107ANFZ0BXSK4\/index.html?docId=yJxAGr8vjV0gDJFRPxnmunfUeuiBYKQ71CaE0uB0PZV2Hkjkoh7LM5\/dgBYosE2g5Idjywpur4wxcSn0oSzwkCtisX14wHh35jep4E3eZdVWzm16U+qWb6xXTACJbXFH."},{"key":"e_1_2_7_51_1","unstructured":"China Judgements Online First\u2010Instance Civil Judgment on the Medical Malpractice Liability Dispute Between Zhan Youyue and defendant Chengdu Eleventh People's Hospital accessed 23 June 2024 https:\/\/wenshu.court.gov.cn\/website\/wenshu\/181107ANFZ0BXSK4\/index.html?docId=NDOtIA+hdMhQ42U5XZuZ3XKmzjYyZzJkrOE+E9AXcjiXmyRM7s5xEZ\/dgBYosE2g5Idjywpur4wxcSn0oSzwkCtisX14wHh35jep4E3eZdXU75DlU6Fjq3OKoRsWVdOR."},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-5-200903030-00107"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.5052"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.5195\/jmla.2022.1419"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14424"},{"issue":"7","key":"e_1_2_7_56_1","first-page":"481","article-title":"Off\u2010Label Drug Use Directory (New Indications in the 2023 Edition)","volume":"33","author":"Guangdong Pharmaceutical Association","year":"2023","journal-title":"Pharmacy Today"},{"issue":"21","key":"e_1_2_7_57_1","first-page":"1876","article-title":"Pharmaceutical Analysis of Judicial Precedents Involving Off\u2010Label Drug Use","volume":"53","author":"Du B.","year":"2018","journal-title":"Chinese Pharmaceutical Journal"},{"issue":"20","key":"e_1_2_7_58_1","first-page":"1829","article-title":"Investigation and Analysis of Clinicians Cognition on Off\u2010Label Drug Use in China","volume":"25","author":"Yang X.","year":"2014","journal-title":"China Pharmacy"},{"volume-title":"The Civil Code of the People's Republic of China","author":"The National People's Congress of the People's Republic of China","key":"e_1_2_7_59_1"},{"key":"e_1_2_7_60_1","unstructured":"National Health Commission of the People's Republic of China.Letter Regarding the Response to Proposal No. 02169 (Medical and Health Proposal No. 193) of the Fifth Plenary Session of the Thirteenth National Committee of the Chinese People's Political Consultative Conference accessed 23 June 2024 http:\/\/www.nhc.gov.cn\/wjw\/tia\/202211\/71d8389d228445cda4aada425a70781a.shtml."},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S321789"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4303-z"},{"issue":"4","key":"e_1_2_7_63_1","first-page":"426","article-title":"Evidence\u2010Based Evaluation on Off\u2010Label Drug Use Policies in 15 Countries","volume":"12","author":"Zhang L.","year":"2012","journal-title":"Chinese Journal of Evidence\u2010Based Medicine"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.159935"},{"key":"e_1_2_7_65_1","unstructured":"AHFS\u00ae Clinical Drug Information For Cancer Uses Medically Acceptable Uses of Antineoplastics and Biologics accessed 29 Nov 2024 https:\/\/ahfsdruginformation.com\/off\u2010label\u2010uses\u2010overview."}],"container-title":["Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jebm.12669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T16:40:35Z","timestamp":1735576835000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jebm.12669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1111\/jebm.12669"],"URL":"https:\/\/doi.org\/10.1111\/jebm.12669","archive":["Portico"],"relation":{},"ISSN":["1756-5383","1756-5391"],"issn-type":[{"type":"print","value":"1756-5383"},{"type":"electronic","value":"1756-5391"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-08-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}